Singhal Lab
Understanding the effects of obesity in pediatric and young adult populations
Research Areas of Interest
Studies Overview
About Us
Our laboratory is interested in understanding and addressing the effects of obesity in pediatric and young adult populations. Pediatric obesity not only increases the risk of chronic diseases such as Type 2 diabetes but also affects reproductive health and subsequent generations. Our research is committed to improving access to and understanding the effectiveness of treatments for severe obesity, including metabolic bariatric surgery and glucagon-like peptide-1 medications (commonly known as Ozempic, Wegovy, Zepbound, Mounjaro, and Saxenda). We are also examining the long-term effects of these interventions on fertility and their implications for future generations.
Vibha Singhal, MBBS, MPH
Ashley Huynh
Ongoing Studies
Dr. Singhal’s lab is participating in the following clinical trials:
- An Addiction-Based Mobile Health Weight Loss Intervention with Coaching
- Determinants of Referral of Adolescents with Severe Obesity to Evaluation for Metabolic and Bariatric Surgery
- Next Generation Effects of Obesity Treatments
- Effectiveness of Anti-Obesity Pharmacotherapy in Individuals with Down Syndrome and Obesity
- A Study of Dulaglutide (LY2189265) 3.0 mg and 4.5 mg in Pediatric Participants with Type 2 Diabetes Mellitus (AWARD-PEDS PLUS)
- Effect of Youth Obesity and Weight Loss on Male Reproductive System
- Effect of Sleeve Gastrectomy and Glucagon-Like Peptide-1 Analog Use in Mothers on Early Life Adiposity and Appetitive Traits in Infants and its Determinants
- Additive Benefits of Addressing Food Insecurity in Adolescents with Obesity
To collaborate with the lab, please contact our team by emailing: [email protected].
Latest Research
An Addiction-Based Mobile Health Weight Loss Intervention with Coaching
The purpose of this study is to develop and evaluate a smartphone app designed to help adolescents manage overeating behaviors.
A Study of Dulaglutide (LY2189265) 3.0 mg and 4.5 mg in Pediatric Participants With Type 2 Diabetes Mellitus (AWARD-PEDS PLUS)
The main purpose of this study is to evaluate additional dosing options for dulaglutide in pediatric participants with Type 2 diabetes.
Effect of Youth Obesity and Weight Loss on Male Reproductive System
This prospective study explores the effects of obesity during puberty and its impact on the male reproductive axis.
Media
Estrogen patch counters eating disorders in women athletes
Blum Center Program: Tips to Manage Childhood Obesity
